期刊文献+

老年非瓣膜性房颤患者“胆固醇悖论”的临床研究

The clinical research of "cholesterol paradox " in elderly patients with nonvalvular atrial fibrillation
下载PDF
导出
摘要 目的:明确老年非瓣膜性房颤患者中“胆固醇悖论”是否存在。方法回顾性分析2012年4月至2013年11月入住北京友谊医院医疗保健中心的符合纳入标准的老年非瓣膜性房颤患者作为房颤组,按照病例对照研究1:1匹配原则以同期体检的非房颤患者作为对照组,对比分析两组的总胆固醇( TC)、低密度脂蛋白胆固醇(LDL - C)、高密度脂蛋白胆固醇(HDL - C)、甘油三酯(TG)水平的变化。结果纳入202例符合标准的非瓣膜性房颤患者,结果发现房颤组 TC、LDL - C 水平分别为4.04±0.81 mmol/ L ,2.27±0.63 mmol/ L;低于对照组,差异具有统计学意义( P 〈0.05)。且 Logstic 回归分析显示胆固醇水平可作为房颤发生的保护因素存在( OR =0.017,95%置信区间为0.003~0.091,P =0.000)。结论老年非瓣膜性房颤患者中 TC、LDL - C 水平较非房颤患者低,“胆固醇悖论”现象确实存在,但产生机制及其所代表的意义仍需要更多临床大型研究去研究证实。 Objective In clinical studies,hypercholesterolemia is an important cardiovascular risk factor,hypercholesterolemia can in-crease the risk for AF. However,several previous studies have demonstrated controversial relationships between cholesterol with AF. The purpose of the stduy was to identify whether the"cholesterol paradox " really existed in the old patients with non - valvular atrial fibrillation(NVAF). Methods 202 inpatients with NVAF admitted to the Beijing Friendship Hospital,Captial Medical University between April 2012 to November 2013 were finally enrolled into this study. In accordance with the principle of case - control study 1:1 matching,202 no - atrial fibrillation patients were served as control group. The changes of blood lipid levels:Total cholesterol(TC),low density lipoprotein(LDL - C),high density lipopro-tein(HDL - C),triglyceride( TG)),in the NVAF group were compared with those of the control group. Results The levels of cholesterol (TC:4. 04 ± 0. 81mmol/ L),low density lipoprotein(LDL - C:2. 27 ± 0. 63 mmol/ L)were lower in NVAF patients compared with those of the control group,and the difference is significant. Furthermore,the cholesterol can be used as a protective factor of AF patients(OR = 0. 017,95%CI 0. 003 - 0. 091,P = 0. 000). Conclusion The TC and LDL - C levels were inversely associated with AF,confirming the "cholesterol para-dox "does exist in AF patients. But it needs more large - scale cohort studies to understand the complex mechanisms and true means.
出处 《临床和实验医学杂志》 2015年第2期146-149,共4页 Journal of Clinical and Experimental Medicine
关键词 心房颤动 胆固醇“胆固醇悖论” Atrial fibrillation Cholesterol(TC) "Cholesterol paradox "
  • 相关文献

参考文献15

  • 1Society of Cardiology, Chinese Medical Association.Retrospective investigation of hospitalized patients with atrial fibrillation in China's Mainland[J].Chinese Medical Journal,2004,17(12):1763-1767. 被引量:23
  • 2Ma CS, Oi WH. Management of atrial fibrillation in Chinese patients [ J]. CVD Prevention and Control, 2009,4( 1 ) :79- 83. 被引量:1
  • 3Chamberlain AM, Agarwal SK, Ambrose M, et al. Metabolic syndrome and incidence of atrial fibrillation among blacks and whites in the Ather- os clerosis Risk in Communities (ARIC) Study [ J ]. Am Heart J, 2010,159 (5) : 850 - 856. 被引量:1
  • 4Haywood LJ, Ford CE, Crow RS, et al. Atrial fibrillation at baseline and during follow - up in ALLHAT ( Antihypertensive and Lipid - Low- ering Treatment to Prevent Heart Attack Trial) [J]. J Am Coll Cardiol, 2009,54 (22) :2023 - 2031. 被引量:1
  • 5Watanabe H, Tanabe N, Yagihara N, et al. Association between lipid profile and risk of atrial fibrillation[ J]. Circ J, 2011,75 (12) :2767 - 2774. 被引量:1
  • 6Iguchi Y, Kimura K, Shibazaki K, et al. Annual incidence of atrial fi- brillation and related factors in adults [ J]. Am J Cardiol, 2010,106 (8) :1129 - 1133. 被引量:1
  • 7Lopez FL, Agarwal SK MacLehose RF, et al. Blood lipid levels, lipid lowering medications, and the Incidence of atrial fibrillation : the ather-osclerosis risk in communities (ARIC) study[ J]. Circ Arrhythm Elec- trophysiol, 2012,5 ( 1 ) : 155 - 162. 被引量:1
  • 8Canun AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - de- veloped with the special contribution of the European Heart Rhythm As- sociation [ J ]. Europace, 2012,14 (10) : 1385 - 1413. 被引量:1
  • 9Suzuki S. "Cholesterol paradox" in atrial fibrillation[J]. Circ J, 2011, 75(12) :2749 -2750. 被引量:1
  • 10Aydin M, Susam I, Kilicaslan B, et al. Serum cholesterol levels and postoperative atrial fibrillation[ J]. J Cardiothorac Surg, 2014,9:69. 被引量:1

二级参考文献10

  • 1PedersenOD,BrendorpB,KoberL ,etal.Prevalence,prognosticsignificance,andtreatmentofatrialfibrillationincongestiveheartfailurewith particularreference to the DIAMOND CH Fstudy[].Congestive Heart Failure.2003 被引量:1
  • 2GoAS ,,HylekEM,PhillipsKA ,etal.Prevalenceofdiagnosedatrialfibrillationinadults:nationalimplicationsforrhythmmanagementandstroke preventionTheanticoagulationandriskfactorsinatrialfibrillaiton(ATRIA)study[].The Journal of The American Medical Association.2001 被引量:1
  • 3SinghBN.Atrialfibrillation:epidemiologicconsiderationsandrationalforconversionandmaintenanceofsinusrhythm[].JCardiovascPharmacolTher.2003 被引量:1
  • 4LehtoM,KalaR.Persistentatrialfibrillation:apopulationbasedstudyofpatientswiththeirfirstcardioversion[].International Journal of Cardiology.2003 被引量:1
  • 5BjerregaardP,BaileyWB,RobinsonSE ,etal.Ratecontrolinpatientswithchronicatrialfibrillation[].The American Journal of Cardiology.2004 被引量:1
  • 6HohnloserSH,KuckKH,LilienthalJ.Rhythmorratecontrolinatrialfibrillagtion pharmacologicalinterventioninatrialfibrillation(PIAF ):arandomizedtrial[].The Lancet.2000 被引量:1
  • 7CarlssonJ,MiketicS,WindelerJ,etal.Randomizedtrialofrate controlversusrhythm controlinpersistentatrialfibrillation(STAF)[].Journal of the American College of Cardiology.2003 被引量:1
  • 8StellbrinkC,NixdorffU,HofmannT ,etal.Safetyandefficacyofenoxaparincomparedwithunfractionatedheparinandoralanticoagulantsfor preventionofthromboemboliccomplicationsincardioversionofnonvalvularatrialfibrillation[].Circulation.2004 被引量:1
  • 9PearceLA,HartRG,HalperinJL.Assesmentofthreeschemesforstratifyingstrokeriskin patientswithnonvalvularatrialfibrillation[].The American Journal of The Medical Sciences.2000 被引量:1
  • 10Hohnloser SH,Kuck KH,Lilienthal J.Rhythm or rate control in atrial fibrillation:pharmacological intervention in atrial fibrilation (PIAF):a randomized trial[].The Lancet.2000 被引量:1

共引文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部